Xact Kapitalforvaltning AB Invests $230,000 in LifePoint Health (LPNT)

Xact Kapitalforvaltning AB purchased a new position in LifePoint Health (NASDAQ:LPNT) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 4,623 shares of the company’s stock, valued at approximately $230,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in LPNT. Millennium Management LLC raised its holdings in shares of LifePoint Health by 583.3% in the fourth quarter. Millennium Management LLC now owns 947,579 shares of the company’s stock worth $47,189,000 after acquiring an additional 808,906 shares during the last quarter. American Century Companies Inc. raised its holdings in shares of LifePoint Health by 16.3% in the fourth quarter. American Century Companies Inc. now owns 4,220,590 shares of the company’s stock worth $210,185,000 after acquiring an additional 590,103 shares during the last quarter. Boston Partners raised its holdings in shares of LifePoint Health by 50.8% in the fourth quarter. Boston Partners now owns 874,690 shares of the company’s stock worth $43,559,000 after acquiring an additional 294,480 shares during the last quarter. First Trust Advisors LP raised its holdings in shares of LifePoint Health by 33.4% in the fourth quarter. First Trust Advisors LP now owns 414,248 shares of the company’s stock worth $20,630,000 after acquiring an additional 103,680 shares during the last quarter. Finally, WINTON GROUP Ltd raised its holdings in shares of LifePoint Health by 94.4% in the fourth quarter. WINTON GROUP Ltd now owns 204,098 shares of the company’s stock worth $10,164,000 after acquiring an additional 99,104 shares during the last quarter.

How to Become a New Pot Stock Millionaire

In other LifePoint Health news, Chairman William F. Carpenter III acquired 21,368 shares of the stock in a transaction dated Wednesday, February 28th. The stock was acquired at an average price of $46.80 per share, with a total value of $1,000,022.40. Following the completion of the transaction, the chairman now directly owns 482,668 shares in the company, valued at $22,588,862.40. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 8.76% of the stock is owned by insiders.

Shares of NASDAQ:LPNT opened at $48.50 on Tuesday. The firm has a market capitalization of $1,872.88, a PE ratio of 13.36, a price-to-earnings-growth ratio of 1.46 and a beta of 0.49. The company has a quick ratio of 1.49, a current ratio of 1.70 and a debt-to-equity ratio of 1.26. LifePoint Health has a 52 week low of $41.45 and a 52 week high of $67.95.

LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings data on Friday, February 23rd. The company reported $0.77 EPS for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.04). The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.58 billion. LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. LifePoint Health’s revenue for the quarter was down 7.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.07 EPS. research analysts anticipate that LifePoint Health will post 4.23 earnings per share for the current fiscal year.

A number of equities analysts have recently weighed in on LPNT shares. BidaskClub raised LifePoint Health from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Robert W. Baird reissued a “buy” rating and issued a $54.00 price target on shares of LifePoint Health in a report on Tuesday, March 27th. Morgan Stanley reissued an “equal weight” rating and issued a $46.00 price target (down from $50.00) on shares of LifePoint Health in a report on Monday, February 26th. SunTrust Banks cut their price target on LifePoint Health to $44.00 and set a “hold” rating for the company in a report on Monday, February 26th. Finally, ValuEngine cut LifePoint Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and seven have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $54.31.

COPYRIGHT VIOLATION NOTICE: “Xact Kapitalforvaltning AB Invests $230,000 in LifePoint Health (LPNT)” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at https://www.chaffeybreeze.com/2018/04/17/xact-kapitalforvaltning-ab-invests-230000-in-lifepoint-health-lpnt.html.

LifePoint Health Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply